Takeda Ventures, Inc. - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of BiomX Inc (PHGE.U) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of BiomX Inc (PHGE.U) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

BiomX Inc (PHGE.U)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Takeda Ventures, Inc. made no insider transaction in Quince Therapeutics Inc (QNCX). Other recent insider transactions involving Quince Therapeutics Inc (QNCX) include a net purchase of 500,436 shares made by David Lamond , a net purchase of 322,500 shares made by Dirk Thye , and a net purchase of 110,686 shares made by Brendan Hannah .

In summary, during the past 3 months, insiders sold 0 shares of Quince Therapeutics Inc (QNCX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Quince Therapeutics Inc (QNCX) were sold and 990,009 shares were bought by its insiders, resulting in a net purchase of 990,009 shares.

Quince Therapeutics Inc (QNCX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Takeda Ventures, Inc. made no insider transaction in BiomX Inc (PHGE). Other recent insider transactions involving BiomX Inc (PHGE) include a net sale of 24,344 shares made by Orbimed Israel Biofund Gp Limited Partnership , and a net sale of 10,914 shares made by Assaf Oron .

In summary, during the past 3 months, insiders sold 0 shares of BiomX Inc (PHGE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,526 shares of BiomX Inc (PHGE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 3,526 shares.

BiomX Inc (PHGE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Takeda Ventures, Inc. made no insider transaction in Xilio Therapeutics Inc (XLO). Other recent insider transactions involving Xilio Therapeutics Inc (XLO) include a net purchase of 2,245,228 shares made by Gilead Sciences Inc , and a net sale of 5,235 shares made by Atlas Venture Fund Xi, L.p. .

In summary, during the past 3 months, insiders sold 0 shares of Xilio Therapeutics Inc (XLO) in total and bought 1,759,978 shares, with a net purchase of 1,759,978 shares. During the past 18 months, 5,235 shares of Xilio Therapeutics Inc (XLO) were sold and 2,245,228 shares were bought by its insiders, resulting in a net purchase of 2,239,993 shares.

Xilio Therapeutics Inc (XLO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Takeda Ventures, Inc. made no insider transaction in Day One Biopharmaceuticals Inc (DAWN). Other recent insider transactions involving Day One Biopharmaceuticals Inc (DAWN) include a net sale of 240,340 shares made by Samuel C. Blackman , a net sale of 122,037 shares made by Jeremy Bender , and a net sale of 72,915 shares made by York Charles N Ii .

In summary, during the past 3 months, insiders sold 88,527 shares of Day One Biopharmaceuticals Inc (DAWN) in total and bought 0 shares, with a net sale of 88,527 shares. During the past 18 months, 463,467 shares of Day One Biopharmaceuticals Inc (DAWN) were sold and 1,475,454 shares were bought by its insiders, resulting in a net purchase of 1,011,987 shares.

Day One Biopharmaceuticals Inc (DAWN)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Calithera Biosciences Inc (CALA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Calithera Biosciences Inc (CALA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Calithera Biosciences Inc (CALA)'s detailed insider trading history can be found in Insider Trading Tracker table.